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Abstract
Background: Tetralogy of Fallot (ToF) is the most common cyanotic congenital heart disease and the population
of ToF repair survivors is growing rapidly. Adults with repaired ToF develop late complications. The aim of this
study was to describe and analyze long-term follow-up of patients with repaired ToF.
Methods: This is a retrospective cohort study. Consecutive 83 patients with repaired ToF who did not undergo
pulmonary valve replacement were included. Mean age of all patients was 30.5 ± 10.7. There were 49 (59%) male.
Patients were divided into two groups according to the time since the repair (< 25 years and ≥ 25 years). The
electrocardiographic (ECG), cardiopulmonary exercise testing (CPET), echocardiographic and cardiac magnetic
resonance (CMR) data were reviewed retrospectively.
Results: In CPET values were not significantly different in the two groups. In CMR volumes of left and right ventricles
were not significantly different in the two groups. There were no differences between the groups in ventricular
ejection fraction, mass of ventricles, or pulmonary regurgitation fraction. Among all the patients, ejection fraction and
left and right ventricle mass, indexed pulmonary regurgitation volume measured by CMR did not correlate with the
time since repair. In ECG among all the patients, ejection fraction of the RV, measured in CMR, negatively correlated
with QRS duration (r = − 0.43; p < 0.001). There was a positive correlation between QRS duration and end diastolic
volume of the RV (r = 0.30; p < 0.02), indexed end diastolic volume of the RV (r = 0.29; p = 0.04), RV mass (r = 0.36;
p < 0.001) and left ventricle mass (r = 0.26; p = 0.04).
Conclusion: Long-term survival and clinical condition after surgical correction of ToF in infancy is generally good and
the late functional status in ToF – operated patients could be excellent up to 25 years after the repair. QRS duration
could be an utility and easy factor to assessment of right ventricular function.
Trial registration: The study protocol was approved by the local Ethics Committee. Each participant provided informed
consent to participate in the study (license number 122.6120.88.2016 from 28.04.2016).
Keywords: Tetralogy of Fallot, Long term follow up, Cardiac magnetic resonance, Echocardiography cardiopulmonary
exercise test
Background
Tetralogy of Fallot (ToF) is the most common cyanotic
congenital heart disease [1, 2]. Surgical correction of ToF
has become the treatment of choice over four decades ago
[3] and is well established [4]. As a result, survival has im-
proved significantly and the population of ToF repair sur-
vivors is growing rapidly [1], with a 20–30-year survival
rate at near 90% [1, 2, 5]. Nevertheless, survival at 30 years
is lower than in the normal population [2], and the risk of
death in the third postoperative decade is more than triple
[5]. Adults with repaired ToF develop late complications,
such as progressive exercise intolerance, arrhythmias, and
heart failure [4, 6]. These complications are mainly due to
pulmonary regurgitation, which leads to right ventricle
dysfunction [7]. Previous studies have focused on out-
comes of pulmonary valve replacement [8, 9] and risk fac-
tors assessment for adverse events [2, 10], but few have
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reported a long-term symptomatic status of patients after
ToF repair.
The primary aim of this study was to describe and
analyze long-term follow-up of patients with repaired
ToF. The secondary aim was to assess the patients’ exer-
cise capacity and type and frequency of complications.
Methods
Patient population
This is a retrospective cohort study. Consecutive patients
with repaired ToF were included from the outpatients
registry if they were > 18 years of age. Patients were re-
ferred for clinical assessment as part of routine clinical
follow-up at the Department of Cardiac and Vascular
Diseases, Institute of Cardiology Jagiellonian University
College of Medicine, in the John Paul II Hospital, in
Krakow. A main diagnosis was determined for every pa-
tient from hospital records, and patients were included in
the study if they had only ToF as the primary diagnosis
(ToF variants were excluded). To the further analysis 83
patients who did not undergo PVR were included. Patients
were divided into two groups according to the time since
the repair (< 25 years and ≥ 25 years). In patients popula-
tion who did undergo PVR the data were obtained after
PVR.
Study protocol
All clinical and demographic variables were extracted
from the patients’ medical records. Body mass index
(BMI) was computed as weight/ height2 expressed in kg/
m2. [11]. Information on cardiac malformations, type of
previous cardiac operations, age at surgical repair, reo-
perations, and current medications were recorded. The
electrocardiographic (ECG), cardiopulmonary exercise
testing (CPET), echocardiographic and cardiac magnetic
resonance (CMR) data for the patients who did not
undergo pulmonary valve replacement were reviewed
retrospectively.
The study protocol was approved by the local Ethics
Committee (license number 122.6120.88.2016). Each
participant provided informed consent to participate in
the study. All procedures were conducted in accordance
with the ethical standards of the institutional and/or na-
tional research committee and with the 1964 Declaration
of Helsinki and its later amendments, or comparable
ethical standards. The study was funded by Jagiellonian
Universtiy Collegium Medicum (CMUJ K/ZDS/007189;
CMUJ K/ZDS/007820).
ECG and Holter monitoring
Standard (25 mm/s speed and 1 mV/cm) 12-lead surface
ECGs were analysed for rhythm, PQ interval and QRS
duration (defined as the maximal QRS length in any lead
from the first inflection to the final sharp vector crossing
the isoelectric line). ECGs in patients with a pacemaker
were excluded from this comparison. Twenty-four-hour
Holter monitoring, performed with a Pathfinder SL ver-
sion 1.7.1.4557, was analysed for rhythm and conduction
abnormalities.
Cardiopulmonary exercise testing
CPET was performed on a treadmill with a modified
Bruce protocol (Reynolds Medical System, ZAN-600) as
previously described [12]. To avoid pharmacologic influ-
ence, beta blockers were discontinued before CPET.
Oxygen saturation and 12-lead ECG were continually
monitored during the test, and blood pressure was mea-
sured manually every two minutes. Oxygen consumption
(VO2) and carbon dioxide production (VCO2) were
measured with computerized breath-by-breath analyzer.
Peak oxygen uptake (VO2 peak) was defined as the high-
est value at peak workload, expressed in ml/kg/min and
as % of predicted value.
Echocardiography
During echocardiographic examination, ejection fraction
of the left and right ventricle, according to the European
Society of Cardiology guidelines, was measured [13].
Valves regurgitations and stenoses were evaluated with
continuous wave Doppler and pulsed- wave Doppler. To
estimate the severity of pulmonary stenosis, pulmonary
gradient with continuous wave Doppler was measured.
The severity of pulmonary and tricuspid regurgitation
was estimated with the color Doppler. A quantitative
assessment of the severity of pulmonary regurgitation
was based on the deceleration velocity of the regurgitant
flow, known as pressure half time (PHT). The PHT was
measured with continuous wave Doppler. Function of
the right heart was assessed by tricuspid annular-plane
systolic excursion (TAPSE). Values of TAPSE lower than
18 mm were indicative of right ventricular longitudinal
dysfunction [14]. Tissue Doppler imaging technique was
applied at the tricuspid annulus to measure its systolic
velocity (S′). The presence or absence of atrial and ven-
tricle septal defect was checked. Images were obtained
with Vivid 7 GE Medical System, USA.
Cardiac magnetic resonance: imaging protocol
Breath-hold, ECG-gated imaging was performed by use
of cardiac phased-array coil on 1.5 T whole-body scan-
ner (Magnetom Sonata Maestro Class, Siemens,
Erlangen, Germany) in left and right ventricle short-axis
and axial views. After scout imaging was performed, cine
biventricular imaging, using breath-hold steady-state free
precision gradient echo technique, and flow-sensitive
imaging at the pulmonary valve level, using free-breathing
phase-contrast technique, were acquired. The imaging
plane for a flow sequence was oriented perpendicularly to
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the main pulmonary artery at the pulmonary valve level.
The velocity encoding was set at 100–550 cm/sec to avoid
an aliasing artefact.
Cardiac magnetic resonance: image analysis
Cine and flow images were assessed off-line with dedi-
cated software package (MASS Medis, Leiden, the
Netherlands). Left ventricular and right ventricular
end-diastolic volume, end-systolic volume, ejection frac-
tion, and myocardial mass were computed. End-diastolic
volume, end-systolic volume and pulmonary regurgita-
tion fraction were indexed to body surface area.
Flow images
The forward flow and backward flow were calculated.
Backward flow was considered to represent the volume
of pulmonary regurgitation. Based on the forward and
backward flow volumes, the fraction of pulmonary re-
gurgitation (PRF) was calculated.
Statistical analysis
Data were analyzed by use of statistical software package
StatSoft STATISTICA 12.5. A p value of < 0.05 was con-
sidered statistically significant. Continuous variables are
presented as mean ± SD or median with range. Student’s
unpaired t-test and Mann-Whitney U test were used for
comparison of continuous variables. All categorical vari-
ables were compared by use of the χ2 test. The age dif-
ference between the groups according to the time after
the surgery was compensated for in statistical analysis.
To assess the effects of the time-dependent covariates,
repeated multivariate analyses of variance were per-
formed. In case of significant results of these analyses,
post-hoc testing was applied. Correlations between nom-
inal variables were tested with Spearman’s rank correl-
ation coefficient test or Pearson’s rank correlation




The total cohort of ToF patients was 109. The median
age of all patients was 28 years (interquartile range 19–
64). There were 64 (59%) male. 57 (52.3%) of patients
were in I NYHA class, 38 (34.9%) in II NYHA class and
14 (12.8%) in III NYHA class. The corrective surgery
was performed between 1964 and 2012; the median pa-
tients age of intracardiac repair was 3.0 years (interquar-
tile range 0.0–31.0 years). The mean time from repair to
study was 26.1 ± 8.3 years. Twenty (18%) patients had re-
ceived a palliative shunt (Blalock-Taussig repair) prior to
complete repair. The most common surgical procedure
was transannular patch, performed in 54 (49%) patients.
Twenty-six patients were qualified for reoperation
according to European Society of Cardiology guidelines
[15] and underwent pulmonary valve replacement. The
median age at PVR was 30.5 (interquartile range 19–53).
To the further analysis 83 patients (76%), of median age
of 26 years (interquartile range 19–64), who did not
undergo PVR were included. None of the patients of this
population had the criteria for reintervention at the time
of the study. Patients were divided into two groups
according to the time since the repair (< 25 years
and ≥ 25 years). Table 1 illustrates the demographics
and surgical characteristics of patients who did not
undergo PVR after ToF repair.
Cardiopulmonary exercise testing
The results of cardiopulmonary exercise test are pre-
sented in Table 2. Patients who were ≥ 25 years since the
repair had significantly lower peak heart rate. Other
values were not significantly differe in the two groups.
Echocardiography
Echocardiography was completed in all patients. The
results of echocardiography are presented in Table 3.
Moderate or severe pulmonary regurgitation was present
in 69 subjects (83%), and severe tricuspid regurgitation
was present in 4 (5%). Hemodynamically insignificant
residual ventricular septal defect, was present in 16
patients (19%).
The patients with less than 25 years since the repair
had significantly smaller right and left atria than did the
patients operated before that time.
Cardiac magnetic resonance
The results of cardiac magnetic resonance are presented
in Table 4. Volumes of left and right ventricles were not
significantly different in the two groups. Also, there were
no differences between the groups in ventricular ejection
fraction, mass of ventricles, or pulmonary regurgitation
fraction.
Among all the patients, ejection fraction and left and
right ventricle mass, indexed pulmonary regurgitation
volume measured by CMR did not correlate with the
time since repair.
ECG and Holter monitoring
Patients’ ECG and Holter monitor findings are illus-
trated in the figure below (Fig. 1). Among all the pa-
tients, 77 (93%) had sinus rhythm, 6 (7%) had persistent
atrial fibrillation, which was the most common
arrhythmia. Most of the patients (69, 83%) had right
bundle branch block; 13 (17%) had episodes of ventricu-
lar tachycardia, 9 (11%) atrioventricular block; and 40
(48%) were treated with beta blocker.
Ventricular tachycardia and the need to use beta
blocker medications were significantly less frequent in
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patients who were < 25 years since the repair as com-
pared to operated later (13 vs 70; p = 0.002 and 40 vs 43;
p = 0.003, respectively). There were no statistically sig-
nificant differences between these groups in PQ interval
duration (176 ms vs 191 ms; p = 0.3) or QRS interval
duration (138 ms vs 132 ms; p = 0.5).
Among all the patients, ejection fraction of the right
ventricle, measured in CMR, negatively correlated with
QRS duration (r = − 0.43; p < 0.001). There was a positive
correlation between QRS duration and end diastolic vol-
ume of the right ventricle (r = 0.30; p < 0.02), indexed
end diastolic volume of the right ventricle (r = 0.29; p =
0.04), right ventricle mass (r = 0.36; p < 0.001) and left
ventricle mass (r = 0.26; p = 0.04).
Discussion
The main finding of the study is to show that the late
functional status in ToF – operated patients could be ex-
cellent up to 25 years after the repair. However, after
more than 25 years since the repair, significant changes
can occur, manifesting itself as progressive RV dilation
and dysfunction or clinical arrhythmia.
Good functional status up to 25 years after the oper-
ation corresponds with other reports of excellent
long-term outcomes [17–19]. Most prior studies focused
on risk factors for pulmonary valve regurgitation and pre-
operative or postoperative testing. In contrast with some
studies [16], we did not evaluate patients who had under-
gone reoperation; thus, our data are unique in this regard.
Table 2 Results of patients’ cardiopulmonary exercise testing of patients who did not undergo PVR
CPET variable Mean value ± SD (n = 83) Group 1 < 25 years since repair (n = 43) Group 2≥ 25 years since repair (n = 40) p value
T [min] 16.3 ± 3.3.4 16.9 ± 3.6 15.5 ± 2.8 0.08
HR peak [beat/min] 157 ± 29 164 ± 29 146 ± 26 < 0.001
HR peak [%N] 70 ± 33 71 ± 29 69 ± 35 0.27
SBP peak [mmHg] 141 ± 23 141 ± 18 141 ± 30 0.96
DBP peak [mmHg] 73 ± 12 71 ± 12 75 ± 12 0.23
VO2 peak 1.8 ± 0.7 1.9 ± 0.7 1.7 ± 0.6 0.42
VO2 peak [%N] 69.1 ± 23.0 67.1 ± 23.5 72.0 ± 22.3 0.39
VO2/kg peak [ml/min*kg] 27.6 ± 8.2 28.6 ± 8.6 25.9 ± 7.5 0.18
VO2max/kg [%N] 76.3 ± 22.1 73.4 ± 22.3 80.5 ± 21.5 0.19
VCO2 peak 2.0 ± 0.8 2.0 ± 0.9 1.9 ± 0.7 0.34
VCO2 peak [%N] 57.5 ± 18.3 56.8 ± 19.5 58.4 ± 16.8 0.72
RER peak 1.1 ± 0.2 1.1 ± 0.2 1.1 ± 0.1 0.84
T Time, HR Heart rate, SBP Systolic blood pressure, DBP Diastolic blood pressure, VO2peak Peak oxygen uptake, VO2peak/kg Peak oxygen uptake per kilogram,
VCO2peak Peak carbon dioxide uptake, RER Respiratory exchange ratio
Table 1 Baseline demographics and surgical characteristics of patients who did not undergo PVR
All patients
(n = 83)
Group 1 < 25 years
since repair (n = 51)
Group 2≥ 25 years
since repair (n = 32)
P values
Median age with interquartile range (yr) 26 (19–64) 25 (19–49) 37 (21–64) < 0.001
Male/female 49/34 32/19 17/15 0.39
Height 168.3 ± 10.8 169.9 ± 12.2 165.8 ± 7.7 0.11
Weight 64.7 ± 14.8 63.5 ± 15.4 66.6 ± 14.0 0.40
BMI 22.8 ± 4.4 21.9 ± 4.5 24.1 ± 4.0 0.04
BSA 1.7 ± 0.2 1.7 ± 0.2 1.7 ± 0.2 0.94
Median age with interquartile range at ToF repair (yr) 3 (0–30) 3 (0–30) 3 (0–30) 0.66
Time since ToF repair (yr) 23 (6–53) 21 (6–24) 31 (25–53) < 0.001
Number with prior Blalock – Taussig shunt 17 6 11 0.02
Number with transannular patch 39 29 10 0.02
NYHA functional class NYHA I – 56 NYHA I – 38 NYHA I – 18 0.23
NYHA II – 23 NYHA II – 13 NYHA II – 10 NYHA I – 0.08
NYHA III – 4 NYHA III – 0 NYHA III – 4 NYHA II – 0.38
NYHA IV – 0 NYHA IV –0 NYHA IV –0 NYHA III – 0.98
BMI Body mass index, BSA Body surface area, NYHA New York Heart Association
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Table 3 Results of patients’ echocardiography of patients who did not undergo PVR
Echocardiography parameter Mean value ± SD (n = 83) Group 1 < 25 years since repair (n = 51) Group 2≥ 25 years since repair (n = 32) p value
RVOT prox [mm] 30.5 ± 6.7 29.6 ± 5.8 31.9 ± 7.9 0.14
RDVs [mm] 36.1 ± 8.9 37.7 ± 9.3 33.9 ± 7.7 0.10
RDVd [mm] 71.6 ± 9.9 72.4 ± 10.6 70.3 ± 8.8 0.41
LVD [mm] 44.3 ± 5.9 43.9 ± 6.1 44.9 ± 5.6 0.45
LVS [mm] 28.2 ± 6.0 28.5 ± 4.7 27.7 ± 7.6 0.54
RA area [cm2] 19.3 ± 7.2 17.9 ± 4.9 21.5 ± 9.4 0.04
LA area[cm2] 14.9 ± 5.3 12.8 ± 2.3 17.8 ± 6.6 < 0.001
EF [%] 58.7 ± 20.3 57.9 ± 20.1 60.0 ± 20.8 0.64
PV gr.max [mmHg] 24.3 ± 21.2 22.5 ± 16.3 27.2 ± 27.1 0.33
PV gr.mean [mmHg] 14.0 ± 12.9 12.7 ± 8.6 16.0 ± 17.6 0.26
PV PHT 104.3 ± 58.9 91.1 ± 42.0 126.2 ± 75.2 0.01
Tricuspid annulus [mm] 36.5 ± 7.3 36.0 ± 7.6 37.4 ± 6.8 0.57
TAPSE [mm] 21.2 ± 4.3 21.3 ± 4.1 21.2 ± 4.5 0.94
S′ [cm/s] 11.7 ± 2.0 11.8 ± 1.9 11.4 ± 2.1 0.43
RVSP (mmHg) 38.8 ± 16.5 36.0 ± 12.3 42.2 ± 20.4 0.20
RVOT Right ventricle outflow track, RDVs Right ventricle dimension at end systole, RDVd Right ventricle dimension at end diastole, LVD Left ventricle diastolic
dimension, LVS Left ventricle systolic dimension, LA Left atrium, RA Right atrium, EF Ejection fraction, PV gr max Maximal pulmonary valve gradient, PV gr min
Minimal pulmonary valve gradient, PV PHT Pulmonary valve pressure half time, TAPSE Tricuspid annular plane systolic excursion, S’ Systolic velocity of tricuspid
annulus, RVSP Right ventricular systolic pressure
Table 4 Results of patients’ cardiac magnetic resonance of patients who did not undergo PVR
CMR parameter Mean value ± SD (n = 83) Group 1 < 25 years since repair (n = 51) Group 2≥ 25 years since repair (n = 32) p value
LA area [cm2] 20.2 ± 5.1 19.6 ± 5.4 21.1 ± 4.5 0.18
RA area [cm2] 26.3 ± 8.2 24.9 ± 7.2 28.4 ± 9.2 0.06
RV area [cm2] 41.9 ± 10.3 43.2 ± 11.0 40.3 ± 9.4 0.42
LVD [cm] 4.8 ± 0.5 4.7 ± 0.5 4.8 ± 0.5 0.47
LVS [cm] 3.2 ± 0.5 3.2 ± 0.5 3.2 ± 0.5 0.72
RV EF [%] 50.7 ± 9.9 50.2 ± 8.9 51.5 ± 11.3 0.57
RV EDV [ml] 197.4 ± 61.9 202.6 ± 58.0 189.0 ± 67.8 0.33
RV EDV indexed [ml/m2] 112.9 ± 33.8 118.4 ± 28.4 103.8 ± 40.0 0.07
RV ESV [ml] 104.0 ± 47.8 95.4 ± 35.8 122. ± 65.5 0.17
RV ESV indexed [ml/m2] 59.8 ± 27.9 55.9 ± 16.8 66.7 ± 41.5 0.39
RV mass [g] 46.3 ± 19.5 47.3 ± 19.6 44.9 ± 19.5 0.59
RV mass indexed [g/m2] 27.5 ± 10.6 28.8 ± 10.6 25.7 ± 10.4 0.23
LV EF [%] 57.7 ± 7.6 56.6 ± 7.5 59.3 ± 7.4 0.11
LV EDV [ml] 129.8 ± 35.1 129.9 ± 36.9 129.6 ± 32.5 0.97
LV EDV indexed [ml/m2] 76.3 ± 17.0 76.3 ± 16.1 76.3 ± 18.7 0.99
LV ESV [ml] 56.1 ± 17.9 59.5 ± 18.9 49.7 ± 14.7 0.19
LV ESV indexed [ml/m2] 31.6 ± 8.2 33.6 ± 8.7 28.7 ± 6.6 0.19
LV mass [g] 100.9 ± 31.2 99.6 ± 33.4 102.8 ± 27.9 0.66
LV mass indexed [g/m2] 58.3 ± 14.8 58.3 ± 16.7 58.3 ± 11.8 0.98
PRV [ml] 54.4 ± 30.5 53.7 ± 26.8 55.6 ± 37.0 0.84
PRV indexed [ml/m2] 30.0 ± 17.2 28.0 ± 13.1 34.3 ± 23.7 0.30
PRF [%] 42.0 ± 10.3 42.6 ± 10.7 40.9 ± 10.1 0.67
CMR Cardiac magnetic resonance, LA Left atrium, RA Right atrium, RV Right ventricle, LVD Left ventricle diastolic dimension, LVS Left ventricle systolic dimension,
RVEDV Right ventricle end-diastolic volume, RVESV Right ventricle end-systolic volume, RVEF Right ventricle ejection fraction, RV mass Right ventricle mass, LVEF
Left ventricle ejection fraction, LVEDV Left ventricle end-diastolic volume, LVESV Left ventricle end-systolic volume, LV mass Left ventricle mass, PRV Pulmonary
regurgitation volume, PRF Pulmonary regurgitation fraction
Dłużniewska et al. Cardiovascular Ultrasound           (2018) 16:28 Page 5 of 8
In our cohort, exercise performance in both groups
did not have significant differences in regard to time
since repair. O’Meagher et al. [21] found that the age at
ToF repair did not explain the disparity in exercise cap-
acity. Others [20] have reported that patients after ToF
repair have markedly depressed exercise capacity but in
comparison with healthy controls.
Chronic right ventricular overload due to pulmonary
valve insuficiency can lead to right ventricle dilatation,
dysfunction of both ventricles and arrhythmias [19, 21–
23]. Although previous studies documented that pul-
monary regurgitation can be well tolerated for many
years [24, 25], our data extend these observations and
showed, as did Bacha et al. [23], that right ventricular
volume can be preserved without deterioration for more
than 25 years.
QRS duration is strongly associated with right ven-
tricular function [10], as was first recognized by
Gatzoulis et al. [26], and QRS prolongation has been
correlated with the presence of ventricular arrhythmias
[19]. In contrast to previous findings [10], we found that
QRS interval was not correlated with the length of
follow-up and was not prolonged after 25 years from
date of operation, even though the presence of ventricu-
lar tachycardia increased with time. This should be
obviously noted that beta blockers may affect the QRS.
The relationship between QRS duration and right ven-
tricular enlargement and mass was found primarily in
studies of Book et al. [27] and Neffke et al. [28]. In our
study, we confirmed a significant correlation between
QRS duration and right ventricular mass and end dia-
stolic volume in patients with ToF; also, we made the
new finding of a strong negative relationship between
QRS duration and right ventricular ejection fraction.
Supraventricular and ventricular tachycardia are
well-documented complications of ToF repair [6, 24].
We found an increasing incidence of these arrhythmias
with time from the repair. Abnormal right atrial size has
been shown as a strong predictor of tachyarrhythmia [6],
and we found significant increases in right atrial area
with time since the repair.
Pulmonary regurgitation is a frequent late conse-
quence of repair in ToF patients [25] is associated with
right ventricle dilatation. In natural history, pulmonary
regurgitation leads to ventricular dysfunction and heart
failure developing over time [29]. Our study did not con-
firm time related impairment both ventricles ejection
fractions and relationship to pulmonary regurgitation
volume. This finding supports those of studies which
showed that the right ventricle fails after 40 years of suc-
cessful adaptation [19]. Moreover, in our study, in both
groups right ventricle parameters were not adequate
Fig 1 Patients’ ECG and Holter monitor findings. AF Atrial fibrillation, AV Atrioventricular, RBB Right bundle branch block, VT Ventricular tachycardia
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according to current guidelines to meet criteria of pul-
monary valve replacement or right ventricular failure.
In conclusion, long-term survival and clinical condi-
tion after surgical correction of ToF in infancy is gener-
ally good. Our observations indicate an optimistic
clinical function and exercise capacity in the patients op-
erated more than 25 years ago. QRS duration could be
an utility and easy factor to assessment of right ventricu-
lar function. Additionally longer prospective follow up is
still needed and may provide a clearer understanding of
this group.
Study limitations
The limitations of the study should be mentioned. First,
the small sample of patients population and retrospect-
ive cohort study. Second, this is a cross sectional study
and the parameters and the history of adverse event was
collected at the time of patient enrollment.
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